2,3',4,5'-四甲氧基二苯乙烯

2,3',4,5'-四甲氧基二苯乙烯

中文名称2,3',4,5'-四甲氧基二苯乙烯
中文同义词2,3',4,5'-四甲氧基二苯乙烯;5'-四甲氧基二苯乙烯;化合物TMS;2,3',4,5'-四甲氧基二苯乙烯
英文名称TMS
英文同义词(E)-2,3',4,5'-TETRAMETHOXYSTILBENE;2,3',4,5'-TETRAMETHOXYSTILBENE;1-[(1E)-2-(3,5-DIMETHOXYPHENYL)ETHENYL]-2,4-DIMETHOXY-BENZENE;1-[2,(3,5-DIMETHOXYPHENYL)ETHENYL]-2,4-DIMETHOXYBENZENE;3,5,2’,4’-Tetramethoxystilbene;Benzene, 1-[(1E)-2-(3,5-diMethoxyphenyl)ethenyl]-2,4-diMethoxy-;(E)-1-(3,5-Dimethoxystyryl)-2,4-dimethoxybenzene;TMS, >=98%
CAS号24144-92-1
分子式C18H20O4
分子量300.35
EINECS号
相关类别抑制剂;Antitumour
Mol文件24144-92-1.mol
结构式2,3',4,5'-四甲氧基二苯乙烯 结构式

2,3',4,5'-四甲氧基二苯乙烯 性质

熔点78-79 °C
沸点459.9±40.0 °C(Predicted)
密度1.117±0.06 g/cm3(Predicted)
储存条件Sealed in dry,Store in freezer, under -20°C
溶解度DMF:30mg/mL; DMF:PBS (pH 7.2) (1:1):500 μg/ml; DMSO:20mg/mL;乙醇:400微克/毫升
形态粉末

2,3',4,5'-四甲氧基二苯乙烯 用途与合成方法

TMS ((E)-2,3',4,5'-tetramethoxystilbene) 是一种选择性和竞争性 CYP1B1 抑制剂,IC50 为 6 nM,Ki 值为 3 nM。TMS 对 CYP1A1 (IC50=300 nM) 和 CYP1A2 (IC50=3.1 μM) 的抑制作用较小。TMS 是白藜芦醇的甲基化衍生物,具有抗癌活性。

CYP1B1

6 nM (IC 50 )

CYP1B1

3 nM (Ki)

CYP1A1

300 nM (IC 50 )

CYP1A2

3.1 μM (IC 50 )

TMS, an analogue of resveratrol, is considered to be a potential cancer preventive agent since it is a potent inhibitor of CYP1B1. To assess survival of MCF-7 cells exposed to 1 μM benzo[a]pyrene (BP), 1 μM BP+1 μM TMS and 1 μM BP+4 μM TMS, cells ae incubated for up to 72 h without a media change. Luminescence units from exposed cells, expressed as a percentage of luminescence units from solvent (DMSO)-treated cells at the same time intervals. In all exposure groups, cell viability remains >90% for the first 24 h, but by 72 h, cell survival drops to 60-70%.

To determine the contribution of CYP1B1 in development of hypertension in spontaneously hypertensive rats (SHR), the effect of TMS is examined on in SHR and WKY rats. Systolic BP steadily increases in SHR from 4 weeks of age. Starting from 8 weeks of age, daily injections of TMS reduce systolic BP in SHR to levels observed at the beginning of the experiment (207±7 vs. 129±2 mmHg). Systolic BP is not altered in WKY injected with TMS or its vehicle (129±7 vs. 127±4 mmHg) .

安全信息

MSDS信息

2,3',4,5'-四甲氧基二苯乙烯 上下游产品信息

"2,3',4,5'-四甲氧基二苯乙烯"相关产品信息
4-硝基苯乙烯 氘代二甲亚砜 1-(三甲基硅基)苯并三氮唑 二甲基甲基氢(硅氧烷与聚硅氧烷) 氘代乙腈 氘代苯 四(三甲基硅基)硅烷 氘代吡啶 氘代氯仿 氘代丙酮 N,O-双三甲硅基乙酰胺 二甲基甲酰胺(氘代) 氘代甲醇 氘代甲苯 N-甲基-N-三甲基硅烷基七氟丁酰胺
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》